These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29885745)

  • 21. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
    Ödén J; Eriksson K; Toma-Dasu I
    Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the beam direction search space in computerized non-coplanar beam angle optimization for IMRT-prostate SBRT.
    Rossi L; Breedveld S; Heijmen BJ; Voet PW; Lanconelli N; Aluwini S
    Phys Med Biol; 2012 Sep; 57(17):5441-58. PubMed ID: 22864234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparison of radiotherapy techniques for treatment of the prostate cancer: the three-field vs. the four-field.
    Milecki P; Piotrowski T; Dymnicka M
    Neoplasma; 2004; 51(1):64-9. PubMed ID: 15004663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overlap-volume-histogram based method for rectal dose prediction and automated treatment planning in the external beam prostate radiotherapy following hydrogel injection.
    Yang Y; Ford EC; Wu B; Pinkawa M; van Triest B; Campbell P; Song DY; McNutt TR
    Med Phys; 2013 Jan; 40(1):011709. PubMed ID: 23298079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of three-field coplanar plans for conformal radiotherapy of prostate cancer.
    Khoo VS; Bedford JL; Webb S; Dearnaley DP
    Radiother Oncol; 2000 Apr; 55(1):31-40. PubMed ID: 10788686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the dosimetric impact of non-exclusion of the rectum from the boost PTV in IMRT treatment plans for prostate cancer patients.
    Kassim I; Dirkx ML; Heijmen BJ
    Radiother Oncol; 2009 Jul; 92(1):62-7. PubMed ID: 19278745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rectal dose reduction with IMRT for prostate radiotherapy.
    Hardcastle N; Davies A; Foo K; Miller A; Metcalfe PE
    J Med Imaging Radiat Oncol; 2010 Jun; 54(3):235-48. PubMed ID: 20598012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetric and radiobiological consequences of computed tomography-guided adaptive strategies for intensity modulated radiation therapy of the prostate.
    Battista JJ; Johnson C; Turnbull D; Kempe J; Bzdusek K; Van Dyk J; Bauman G
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):874-80. PubMed ID: 23978708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
    Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
    Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
    Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
    Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of database quality in knowledge-based treatment planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Pract Radiat Oncol; 2018; 8(6):437-444. PubMed ID: 29730280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
    Alongi F; Cozzi L; Fogliata A; Iftode C; Comito T; Clivio A; Villa E; Lobefalo F; Navarria P; Reggiori G; Mancosu P; Clerici E; Tomatis S; Taverna G; Graziotti P; Scorsetti M
    Anticancer Res; 2013 Oct; 33(10):4537-43. PubMed ID: 24123027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Knowledge-based radiation therapy (KBRT) treatment planning versus planning by experts: validation of a KBRT algorithm for prostate cancer treatment planning.
    Nwankwo O; Mekdash H; Sihono DS; Wenz F; Glatting G
    Radiat Oncol; 2015 May; 10():111. PubMed ID: 25957871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
    Pollack A; Hanlon AL; Horwitz EM; Feigenberg SJ; Konski AA; Movsas B; Greenberg RE; Uzzo RG; Ma CM; McNeeley SW; Buyyounouski MK; Price RA
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):518-26. PubMed ID: 16242256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).
    Rancati T; Fiorino C; Gagliardi G; Cattaneo GM; Sanguineti G; Borca VC; Cozzarini C; Fellin G; Foppiano F; Girelli G; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Radiother Oncol; 2004 Oct; 73(1):21-32. PubMed ID: 15465142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fully automated volumetric modulated arc therapy plan generation for prostate cancer patients.
    Voet PW; Dirkx ML; Breedveld S; Al-Mamgani A; Incrocci L; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1175-9. PubMed ID: 24529714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.